Winston Pharmaceuticals, Inc. (WPHM)

OTCMKTS · Delayed Price · Currency is USD

0.0001

0.00 (0.00%)

At close: Aug 14, 2025

Market Cap	7.74K
Revenue (ttm)	1.37M
Net Income (ttm)	-2.34M
Shares Out	77.41M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,186
Average Volume	n/a
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0001
Beta	-1,365.37
RSI	n/a
Earnings Date	n/a

About Winston Pharmaceuticals

Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications. Winston Pharmaceuticals, Inc. was formerly known as Winston Laboratories, Inc. and changed its name to Winston Pharmaceuticals, Inc. in November 2008. The company was incorporate... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1998

Employees 9

Stock Exchange OTCMKTS

Ticker Symbol WPHM

Full Company Profile

Financial Performance

In 2009, Winston Pharmaceuticals's revenue was $1.39 million, an increase of 208.17% compared to the previous year's $452,542. Losses were -$2.66 million, -48.36% less than in 2008.

Financial Statements

News

There is no news available yet.